Skip to main content
Glenn Chertow, MD, Nephrology, Palo Alto, CA

Glenn Matthew Chertow MD

Chronic Renal Failure & Dialysis, Critical Care, Hypertension


Norman S. Coplon Satellite Healthcare Professor of Medicine, Chief, Division of Nephrology

Join to View Full Profile
  • 300 Pasteur DrPalo Alto, CA 94305

  • Phone+1 650-723-6961

  • Fax+1 650-725-9526

Dr. Chertow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1992 - 1995
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1989 - 1992
  • Harvard Medical School
    Harvard Medical SchoolClass of 1989

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - 2026
  • MA State Medical License
    MA State Medical License 1991 - 2008
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Analysis of Primary Hyperparathyroidism Screening Among US Veterans with Kidney Stones  
    Simon Conti, Glenn M Chertow, John T Leppert, Alan C Pao, JAMA Surgery
  • PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT  
    Udayan Y Bhatt, Clinton B Wright, Vasilios Papademetriou, Joachim H Ix, Michael G Shlipak, Alfred K Cheung, Mark J Sarnak, Jing Chen, Charles Ginsberg, Glenn M Chertow..., Journal of the American Society of Nephrology
  • Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System  
    Arnold Milstein, Kevin F Erickson, Wolfgang C Winkelmayer, Glenn M Chertow, JAMA

Lectures

  • Dapagliflozin in Patients with Chronic Kidney Disease 
    Cardiometabolic Health Congress, Boston, Massachusetts - 10/2/2013
  • Contrast-Associated AKI: Does It Exist and What Should We Tell Patients? 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Authored Content

  • Analysis of Primary Hyperparathyroidism Screening Among US Veterans with Kidney StonesJuly 2020
  • Market Consolidation and Mortality in Patients Initiating HemodialysisJuly 2018
  • Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney FoundationFebruary 2018

Press Mentions

  • Vafseo® (Vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs
    Vafseo® (Vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAsNovember 6th, 2025
  • CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure
    CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory FailureJune 25th, 2025
  • Patients Opting Out of Medicare at Dialysis Initiation
    Patients Opting Out of Medicare at Dialysis InitiationJanuary 13th, 2025

Grant Support

  • Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocationSTANFORD UNIVERSITY2023–2025
  • Stanford TRANSFORM I2T ProgramSTANFORD UNIVERSITY2019–2025
  • Mentoring Patient-Oriented Clinical Investigators In NephrologyNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Adult And Pediatric Nephrology Research Training ProgramNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Conservative Versus Dialytic Management In Stage V Chronic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: